Canon says to buy U.S.'s Molecular Imprints

TOKYO Thu Feb 13, 2014 9:03pm EST

A logo of Canon Inc is pictured at the company's showroom in Tokyo October 24, 2013. REUTERS/Yuya Shino

A logo of Canon Inc is pictured at the company's showroom in Tokyo October 24, 2013.

Credit: Reuters/Yuya Shino

TOKYO (Reuters) - Japan's Canon Inc said on Friday it would take over Austin, Texas-based Molecular Imprints Inc, which develops nanoimprint lithography systems, in a bid to strengthen its chipmaking equipment business.

Canon has carried out joint development of next-generation semiconductor lithography systems, which plays a key role in the chip fabrication process, with Molecular Imprints and a major semiconductor maker since 2009.

Canon said it decided to make unlisted Molecular Imprints a wholly owned unit after establishing an outlook for volume production using the technology.

Canon did not disclose a price for the acquisition, which the Nikkei business daily estimated at more than 10 billion yen ($98 million).

($1 = 102.1650 Japanese yen)

(Reporting by Chang-Ran Kim; Editing by Dominic Lau)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (2)
OfficeAuto wrote:
Here in Japan Canon claims not to have enough money for proper paying the retirees, employees, adequate research (e.g. access of the Canon research center to literature) but it has enough money to buy “blue sky” technologies. How does this fit together?

Feb 14, 2014 5:35am EST  --  Report as abuse
OfficeAuto wrote:
Where does this money come from? In Japan the Canon Management tells the employees that there is no money for adequate salaries or bonuses, adequate pension funds, enough resources for research (like access to literature – no library for the Reserch Center), researchers can not travel to international conferences, but there is money for buying into a truly “blue sky” technology that has not proven to be useful for any industrial application – so far basic reserch only. What a waste of employees and shareholders money.

Feb 18, 2014 2:19am EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.